ATE53301T1 - Systeme zur verbesserung der durchdringungsfaehigkeit und deren zubereitung. - Google Patents

Systeme zur verbesserung der durchdringungsfaehigkeit und deren zubereitung.

Info

Publication number
ATE53301T1
ATE53301T1 AT87112412T AT87112412T ATE53301T1 AT E53301 T1 ATE53301 T1 AT E53301T1 AT 87112412 T AT87112412 T AT 87112412T AT 87112412 T AT87112412 T AT 87112412T AT E53301 T1 ATE53301 T1 AT E53301T1
Authority
AT
Austria
Prior art keywords
preparation
systems
improving performance
component
transmembranally
Prior art date
Application number
AT87112412T
Other languages
English (en)
Inventor
Majid Mahjour
Uma Iyer
Mahdi B Fawzi
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25413211&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE53301(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of ATE53301T1 publication Critical patent/ATE53301T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
AT87112412T 1986-08-27 1987-08-26 Systeme zur verbesserung der durchdringungsfaehigkeit und deren zubereitung. ATE53301T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/900,865 US4908389A (en) 1986-08-27 1986-08-27 Penetration enhancement system
EP87112412A EP0261429B1 (de) 1986-08-27 1987-08-26 Systeme zur Verbesserung der Durchdringungsfähigkeit und deren Zubereitung

Publications (1)

Publication Number Publication Date
ATE53301T1 true ATE53301T1 (de) 1990-06-15

Family

ID=25413211

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87112412T ATE53301T1 (de) 1986-08-27 1987-08-26 Systeme zur verbesserung der durchdringungsfaehigkeit und deren zubereitung.

Country Status (8)

Country Link
US (1) US4908389A (de)
EP (1) EP0261429B1 (de)
JP (1) JPS63126832A (de)
AT (1) ATE53301T1 (de)
CA (1) CA1316825C (de)
DE (1) DE3763011D1 (de)
ES (1) ES2036199T3 (de)
GR (1) GR3000536T3 (de)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4788064A (en) * 1987-07-31 1988-11-29 Warner-Lambert Company Transdermal delivery system
US4994267A (en) * 1988-03-04 1991-02-19 Noven Pharmaceuticals, Inc. Transdermal acrylic multipolymer drug delivery system
US5164406A (en) * 1988-06-02 1992-11-17 Bristol-Myers Squibb Co. Method for enhancing transdermal penetration and compositions useful therein
US5238944A (en) * 1988-12-15 1993-08-24 Riker Laboratories, Inc. Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine
US5736553A (en) * 1988-12-15 1998-04-07 Riker Laboratories, Inc. Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo 4,5-C!quinolin-4-amine
US5332577A (en) * 1988-12-27 1994-07-26 Dermamed Transdermal administration to humans and animals
US5241925A (en) * 1988-12-27 1993-09-07 Dermamed Apparatus and techniques for administering veterinary medicaments
US4973468A (en) * 1989-03-22 1990-11-27 Cygnus Research Corporation Skin permeation enhancer compositions
US5059426A (en) * 1989-03-22 1991-10-22 Cygnus Therapeutic Systems Skin permeation enhancer compositions, and methods and transdermal systems associated therewith
US5053227A (en) * 1989-03-22 1991-10-01 Cygnus Therapeutic Systems Skin permeation enhancer compositions, and methods and transdermal systems associated therewith
AU643230B2 (en) * 1989-08-17 1993-11-11 Schering Corporation Transdermal nitroglycerin patch with penetration enhancers
US5262165A (en) * 1992-02-04 1993-11-16 Schering Corporation Transdermal nitroglycerin patch with penetration enhancers
CA2067820A1 (en) * 1989-10-23 1991-04-24 Srinivasan Venkateshwaran Iontophoresis device and method using a rate-controlling membrane
AR246186A1 (es) * 1989-11-17 1994-07-29 Beta Pharm Co Procedimiento para fabricar un dispositivo para administrar estradiol por via transdermica.
US5324521A (en) * 1989-12-18 1994-06-28 Dermamed Systems for transdermal administration of medicaments
AU653156B2 (en) * 1990-06-14 1994-09-22 Dermamed Transdermal administration to humans and animals
SE9003665D0 (sv) * 1990-11-16 1990-11-16 Kabivitrum Ab Morphine prodrugs
TW206152B (de) * 1991-03-20 1993-05-21 Kuko Seiyaku Kk
GB9109965D0 (en) * 1991-05-07 1991-07-03 Unilever Plc Cosmetic composition
US5518734A (en) * 1991-09-25 1996-05-21 Beta Pharmaceuticals Co. Transdermal delivery system for estradiol and process for manufacturing said device
US5705185A (en) * 1991-09-25 1998-01-06 Beta Pharmaceuticals Co. Transdermal delivery of estradiol and process for manufacturing said device
US5229130A (en) * 1991-12-20 1993-07-20 Cygnus Therapeutics Systems Vegetable oil-based skin permeation enhancer compositions, and associated methods and systems
US5453279A (en) * 1992-04-21 1995-09-26 Tbs Laboratories, Inc. Enhancing transdermal absorption compositions; transdermal dosage form; and process
US5900250A (en) * 1992-05-13 1999-05-04 Alza Corporation Monoglyceride/lactate ester permeation enhancer for oxybutnin
NZ274711A (en) * 1993-09-29 1996-11-26 Alza Corp Composition for administration of active agent by application to a body surface or membrane comprising permeability enhancing amount of monoglyceride(s) and lactate ester(s)
US5601839A (en) * 1995-04-26 1997-02-11 Theratech, Inc. Triacetin as a penetration enhancer for transdermal delivery of a basic drug
US6290986B1 (en) * 1996-10-24 2001-09-18 Pharmaceutical Applications Associates, Llc Method and composition for transdermal administration of pharmacologic agents
US5980898A (en) 1996-11-14 1999-11-09 The United States Of America As Represented By The U.S. Army Medical Research & Material Command Adjuvant for transcutaneous immunization
US20060002949A1 (en) 1996-11-14 2006-01-05 Army Govt. Of The Usa, As Rep. By Secretary Of The Office Of The Command Judge Advocate, Hq Usamrmc. Transcutaneous immunization without heterologous adjuvant
US20060002959A1 (en) * 1996-11-14 2006-01-05 Government Of The United States Skin-sctive adjuvants for transcutaneous immuization
US6797276B1 (en) 1996-11-14 2004-09-28 The United States Of America As Represented By The Secretary Of The Army Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response
ID26296A (id) * 1997-09-25 2000-12-14 Lohmann Therapie Syst Lts Garam penambahan asam dari alkaloid morfin dan penggunaannya
US20040258703A1 (en) * 1997-11-14 2004-12-23 The Government Of The Us, As Represented By The Secretary Of The Army Skin-active adjuvants for transcutaneous immunization
EP1143950B1 (de) * 1998-09-10 2005-03-09 BioEqual AG Topisch anwendbare mittel gegen nagelpilzerkrankungen
ES2372592T3 (es) * 1999-04-08 2012-01-24 Intercell Usa, Inc. Formulación seca para la inmunización transcutánea.
IL137559A (en) * 2000-07-27 2006-12-31 Amnon Sintov A system for administering drugs through the skin
US7198801B2 (en) 2000-08-03 2007-04-03 Antares Pharma Ipl Ag Formulations for transdermal or transmucosal application
ATE356636T1 (de) 2000-08-03 2007-04-15 Antares Pharma Ipl Ag Zusammensetzung zur transdermalen und/oder transmukosalen verabreichung von wirkstoffen, die ausreichende therapeutische spiegel garantiert
US8980290B2 (en) 2000-08-03 2015-03-17 Antares Pharma Ipl Ag Transdermal compositions for anticholinergic agents
ATE398461T1 (de) * 2001-02-13 2008-07-15 Us Gov Sec Army Impstoffe zur transkutanen immunisierung gegen reisediarrhö
WO2002089853A2 (en) * 2001-05-03 2002-11-14 Allergan, Inc. Compositions having enhanced pharmacokinetic characteristics
GB0218811D0 (en) * 2002-08-14 2002-09-18 Cenes Ltd Salts of morphine-6-glucuronide
US9498454B2 (en) 2003-02-24 2016-11-22 Pharmaceutical Productions Inc. Transmucosal drug delivery system
US9358296B2 (en) 2003-02-24 2016-06-07 Pharmaceutical Productions Inc. Transmucosal drug delivery system
US9254294B2 (en) 2003-02-24 2016-02-09 Pharmaceutical Productions Inc. Transmucosal hormone delivery system
MXPA06003316A (es) 2003-10-10 2006-06-08 Antares Pharma Ipl Ag Formulacion farmaceutica transdermica para minimizar los residuos en la piel.
US7425340B2 (en) 2004-05-07 2008-09-16 Antares Pharma Ipl Ag Permeation enhancing compositions for anticholinergic agents
US20080139507A1 (en) * 2004-08-26 2008-06-12 Bioderm Research Method of Treating Skin Condition Including Acne, Skin Aging, Body Odor & Diaper Rash by Zinc Zeolite Clathrates
US20070166255A1 (en) * 2004-11-22 2007-07-19 Gupta Shyam K Treatment of Topical Discomforts Including Acne, Sunburn, Diaper Rash, Wound, Wrinkles and Dandruff/Hair Loss by Natural Lignans via Fatty Acid Desaturase Inhibition
US8080560B2 (en) * 2004-12-17 2011-12-20 3M Innovative Properties Company Immune response modifier formulations containing oleic acid and methods
WO2006070653A1 (ja) * 2004-12-27 2006-07-06 Lion Corporation 皮膚外用剤組成物
WO2006125642A1 (en) 2005-05-27 2006-11-30 Antares Pharma Ipl Ag Methods and apparatus for transdermal or transmucosal application of testosterone
US8889154B2 (en) 2005-09-15 2014-11-18 Medicis Pharmaceutical Corporation Packaging for 1-(2-methylpropyl)-1H-imidazo[4,5-c] quinolin-4-amine-containing formulation
WO2007114925A2 (en) * 2006-04-04 2007-10-11 The Trustees Of Columbia University Of In The City Of New York Two pore channels as a therapeutic target to protect against myocardial ischemia and as an adjuvant in cardiac surgery
NZ571460A (en) 2006-04-21 2010-10-29 Antares Pharma Ipl Ag Methods of treating hot flashes with formulations for transdermal or transmucosal application
EP1889609B1 (de) * 2006-07-18 2019-05-22 Meda AB Schaumformulierungen zur Modifikation der Immunantwort
WO2008016475A2 (en) * 2006-07-31 2008-02-07 3M Innovative Properties Company Immune response modifier compositions and methods
EP3056220A1 (de) * 2007-04-11 2016-08-17 John A. Mccarty Hormontablette sowie verfahren zu ihrer herstellung und verwendung
CN101896175B (zh) * 2007-12-12 2013-03-13 帝国制药株式会社 含有环氧洛芬的水性贴剂
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
EP2782584B1 (de) 2011-11-23 2021-06-09 TherapeuticsMD, Inc. Natürliche kombinierte hormonersatzformulierungen und -therapien
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
AU2015264003A1 (en) 2014-05-22 2016-11-17 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1165240A (en) * 1980-07-09 1984-04-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions
EP0095813A3 (de) * 1982-06-01 1985-05-08 THE PROCTER & GAMBLE COMPANY Durchdringende topische pharmazeutische Präparate, die 9-(2-Hydroxyäthoxymethyl)-guanin enthalten
JPS6013711A (ja) * 1983-06-21 1985-01-24 ザ、プロクタ−、エンド、ギヤンブル、カンパニ− コルチコステロイドを含有する浸透局所製薬組成物
US4552872A (en) * 1983-06-21 1985-11-12 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing corticosteroids
DE3343530A1 (de) * 1983-12-01 1985-06-13 Max Planck Gesellschaft Arzneimittel mit verbesserter penetration der gewebsmembran
CA1248450A (en) * 1984-04-05 1989-01-10 Kazuo Kigasawa Soft patch

Also Published As

Publication number Publication date
DE3763011D1 (de) 1990-07-12
JPS63126832A (ja) 1988-05-30
CA1316825C (en) 1993-04-27
EP0261429B1 (de) 1990-06-06
EP0261429A1 (de) 1988-03-30
GR3000536T3 (en) 1991-07-31
ES2036199T3 (es) 1993-05-16
US4908389A (en) 1990-03-13

Similar Documents

Publication Publication Date Title
ATE53301T1 (de) Systeme zur verbesserung der durchdringungsfaehigkeit und deren zubereitung.
IT8467225A1 (it) Composti di solfonio, procedimento di preparazione di detti composti e composizioni farmacologiche contenenti i composti stessi.
DE10075031I2 (de) Zusammensetzung zur kontrollierten Abgabe eines Wirkstoffs.
ES516648A0 (es) "procedimiento para la preparacion de n-(2-piridiloxifenil)-n-benzoilureas substituidas".
DK149059C (da) Analogifremgangsmaade til fremstilling af (ergolin-yl)-n',n'-diethylurinstofderivater
AR241017A1 (es) "procedimiento para la preparacion de fenilsilfoniloxibencimidazolcarbamatos sustituidos".
ES514753A0 (es) "procedimiento para la preparacion de acido d-lactico".
OA07525A (fr) Dérivés d'acides-animés, leur préparation et utilisation ainsi que les compositions contenant ces dérivés.
ES515377A0 (es) "un procedimiento mejorado para la preparacion de urea".
BR8704203A (pt) Compostos,processo para sua preparacao,composicao,racao animal,emprego,processos para a preparacao de composicoes e para a preparacao de racoes
DE3676054D1 (de) Durch waessriges alkali entwickelbare, uv-haertbare urethanacrylatverbindungen und zusammensetzungen, die zur herstellung von beschichtung fuer loetmasken geeignet sind.
IT8621874A0 (it) Procedimento di preparazione di additivi surbasati molto fluidi e a basicita' elevata, e composizione contenente i detti additivi.
ES515227A0 (es) "procedimiento para la preparacion de composiciones poliolefinicas autoextinguentes".
DE3582371D1 (de) Oxindolverbindungen, diese enthaltende zusammensetzungen sowie verfahren zur herstellung derselben.
ES509228A0 (es) "procedimiento para la preparacion de pirroles triciclicos".
AR230987A1 (es) Derivados de s-metil-((n-metil-(n,n-aminosulfenil disustituido)-carbamoil oxi)-tiocetamidato,utiles para la formulacion de composiciones insecticidas,acaricidas y nematocidas,composiciones conteniendolos y procedimientos de preparacion
ES511806A0 (es) "procedimiento para la preparacion de composiciones poliolefinicas autoextinguibles".
ES527155A0 (es) Procedimiento para la preparacion de n-pteridinil-ureas(como divisional de la patente numero 521.331)
ES519831A0 (es) Procedimiento para la preparacion de disulfuros de (2.2')-ditiazolilo.
ES515378A0 (es) "un procedimiento mejorado para la preparacion de urea".
ES8407031A1 (es) "procedimiento para la preparacion de n-(2-metil--5-cloro-fenil)-n-metoxiacetil-3-amino-1,3-oxazilidin-urea"
IT8323139A0 (it) Caviglia per l'assemblaggio di parti di mobili.
ES516406A0 (es) "procedimiento para la preparacion de compuestos de triorganoestanohidantoina".
JPS53113849A (en) Stabilizer composition
AR240316A1 (es) Compuesto derivado del acido 3(2-alquil-primidin-5-il)-2-dimetil cicloproparno carboxilico, composicion que lo contiene,procedimiento para su preparacion y compuesto intermedios utiles en los mismos.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
RZN Patent revoked